Effect of Cotton boll extract in treatment of Cutaneous leishmaniasis

Phase 3

• Conditions: Cutaneous leishmaniasis.; Cutaneous leishmaniasis; B55.1

• Registration Number: IRCT20230903059337N2
• Lead Sponsor: Iran University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 13 November 2023

Recruitment & Eligibility

• Status: Pending
• Sex: All
• Target Recruitment: 120

Inclusion Criteria

patients infected by Leishmania tropica
Number of skin lesions less than 5
Size of lesions less than 5 centimeters
Duration of lesions less than 3 months
Receiving no anti-leishmania remedies during the past 3 months
Completing the informed consent form

Exclusion Criteria

Pregnancy and Lactation
Underlying diseases and Allergy
Lesions on joint, face and sensitive organs
Regional adenopathy

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Size of induration. Timepoint: In 0, 4, 8, 12 weeks of treatment. Method of measurement: By digital caliper.;Size of wound. Timepoint: In 0, 4, 8, 12 weeks of treatment. Method of measurement: Wound Desk app.